Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Stonepine Capital

Timothy P. Lynch

422,310 $10,849 5.86%
2. 153,428 $3,942 +211% 0%
3. 120,000 $3,083 0.01%
4.
Birchview Capital

Matthew Strobeck

40,000 $1,028 +34% 0.61%
5. 20,257 $520 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$25.04 40,886 Officer 0 2021-04-29 Filing
$25.65 507 Officer 0 2021-04-28 Filing
$25.54 10,000 Officer 507 2021-04-28 Filing
$25.25 15,000 Officer 10,507 2021-04-28 Filing
$25.50 10,620 Officer 25,507 2021-04-28 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 8,374 $215,128 0%
2. 1,559,488 $40,062 0%
3. 1,373,000 $35,272 0.52%
4. 1,287,661 $33,080 0.01%
5. 929,481 $23,878 0%
News See All